Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
Sponsor: AstraZeneca
Staphylococcus Aureus
United States
- Danicopan PMS in KoreaRecruiting
Sponsor: AstraZeneca
Paroxysmal Nocturnal Hemoglobinuria
South Korea
Sponsor: AstraZeneca
Non-squamous Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps
China
- Prospective Evaluation of Hepatocellular Carcinoma Surveillance in At-Risk Patients (Screening HCC)Not Yet Recruiting
Sponsor: D'Or Institute for Research and Education
Hepatocellular Carcinoma · Liver Cirrhosis · Chronic Hepatitis B · Metabolic Dysfunction-Associated Steatotic Liver Disease
Sponsor: AstraZeneca
Myasthenia Gravis, Generalized
Poland
- Boosting Regional Integration for COP D Care Through Guided Implementation and Audit of Post Exacerbation Transition BundleActive Not Recruiting
Sponsor: AstraZeneca
COPD
China
- ReAl-woRld Evaluation of tEzepelumab for Chronic rhinoSinusitis With Nasal Polyps in RussiaRecruiting
Sponsor: AstraZeneca
Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) · Asthma
Russia
Sponsor: AstraZeneca
Asthma
United States, China, Mexico, South Africa
- BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC ParticipantsActive Not Recruiting
Sponsor: AstraZeneca
Non-Muscle- Invasive Bladder Cancer
United States
Sponsor: AstraZeneca
Systemic Lupus Erythematosus
Denmark, France, Germany, Spain
- Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLRecruiting
Sponsor: AstraZeneca
B-cell Non-Hodgkin Lymphoma · Follicular Lymphoma (FL) · Large B-Cell Lymphoma (LBCL)
United States, Australia, Brazil, Canada, China +11 more
- An Open-label Study to Assess Safety and Efficacy of SZC in Paediatric Patients With HyperkalaemiaRecruiting
Sponsor: AstraZeneca
Hyperkalaemia
United States, Brazil, Canada, China, Germany +8 more
Sponsor: AstraZeneca
COPD (Chronic Obstructive Pulmonary Disease)
Brazil
Sponsor: AstraZeneca
Endometrial Cancer · Gastric Cancer · Metastatic Castration-resistant Prostate Cancer · Ovarian Cancer
United States, Canada, China, France, Germany +9 more
- Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNsActive Not Recruiting
Sponsor: AstraZeneca
Neurofibroma, Plexiform
China
Sponsor: AstraZeneca
Severe Eosinophilic Asthma
China
Sponsor: AstraZeneca
Chronic Kidney Disease
China
- First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursRecruiting
Sponsor: AstraZeneca
Hepatocellular Carcinoma
United States, China, Hong Kong, Japan, South Korea +2 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PNActive Not Recruiting
Sponsor: AstraZeneca
Neurofibromatosis Type 1
United States, Germany, Italy, Japan, Netherlands +2 more
- Real-World Outcomes of Resected EGFR-Mutated NSCLC Patients Treated With Adjuvant EGFR-TKI in ChinaRecruiting
Sponsor: AstraZeneca
Lung Cancer
China
- A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234Active Not Recruiting
Sponsor: AstraZeneca
Healthy Participants
United Kingdom
- SIRT With Tremelimumab and Durvalumab for Resectable HCCActive Not Recruiting
Sponsor: Jiping Wang, MD, PhD
Resectable Hepatocellular Carcinoma · Hepatocellular Carcinoma · Hepatocellular Cancer
United States
- Observational Study Protocol: LIVER-RRecruiting
Sponsor: AstraZeneca
Hepatobiliary Cancers
United States, Australia, Austria, Belgium, Brazil +17 more